"We really have to work on our implicit bias, acknowledging it, understanding it, and doing the work to try to change it," Veronica Gillispie-Bell, MD, MAS, says.
RADNOR, Pa. (BUSINESS WIRE) $MRNS #MarinusPharma Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the speakers for its upcoming Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m..